Omega Healthcare Investors (OHI) FY2018 results: revenue $882 million, down 2.9% on the year
Omega Healthcare Investors Inc. (OHI) reported revenue of $882 million for fiscal 2018, the year ended 31 December 2018, down 2.9% on the year before. Net income was $282 million, up 180.4%, and diluted earnings per share $1.40. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2019.
Revenue
$882 million
-2.9% on the year
FY2011FY2018
Operating margin
56.4%
34.7% a year earlier
FY2011FY2018
Net income
$282 million
+180.4% on the year
FY2011FY2018
Diluted EPS
$1.40
+174.5% on the year
FY2011FY2018
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Revenue
882
908
901
-2.9%
Operating income
498
315
560
+57.9%
Operating margin
56.4%
34.7%
62.2%
Interest expense
192
189
164
+2.0%
Pre-tax income
297
106
384
+179.9%
Income tax
3.0
3.2
1.4
-7.3%
Effective tax rate
1.0%
3.1%
0.4%
Net income
282
100
366
+180.4%
Net margin
31.9%
11.1%
40.7%
Diluted EPS
$1.40
$0.51
$1.90
+174.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Operating cash flow
499
578
626
-13.6%
Capital expenditure
29.8
37.8
40.5
-21.0%
Free cash flow
470
540
585
-13.1%
Free cash flow margin
53.3%
59.5%
65.0%
Cash from investing
-173
-285
-1,114
Cash from financing
-411
-304
576
Depreciation and amortisation
281
288
267
-2.2%
Share-based compensation
16.0
15.2
13.8
+5.1%
Dividends paid
529
503
453
+5.2%
Dividend per share
$2.64
$2.54
$2.36
+3.9%
Diluted shares, weighted
210m
207m
202m
+1.4%
Shares outstanding at period end
202m
198m
196m
+2.0%
Balance sheet
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Shareholders' equity
3,444
3,555
3,859
-3.1%
Non-controlling interest
320
333
353
-3.9%
Debt
4,541
4,572
4,367
-0.7%
Other liabilities
286
313
370
-8.7%
Total liabilities and equity
8,591
8,773
8,949
-2.1%
Goodwill
644
645
643
-0.1%
Cash and equivalents
10.3
85.9
93.7
-88.0%
Other assets
7,937
8,043
8,212
-1.3%
Total assets
8,591
8,773
8,949
-2.1%
10-K for the year ended 31 December 2018, filed 26 February 2019: the filing.